ICD-10-PCS Code	Code Description	FY 2017		FY 2018		FY 2019		FY 2020		
		Frequency 	Approved as a New Technology? 	Frequency 	Approved as a New Technology? 	Frequency 	Approved as a New Technology? 	Frequency 	Approved as a New Technology? 	Total Frequency Procedure Code Reported
X2A5312	"Cerebral embolic filtration, dual filter in innominate artery and left common carotid artery, percutaneous approach, new technology group 2"	142	NO	"1,957"	NO	"4,598"	YES	N/A	YES	"6,697"
X2RF032	"Replacement of aortic valve using zooplastic tissue, rapid deployment technique, open approach, new technology group 2"	541	NO	1400	YES	1066	NO	N/A	NO	"3,007"
X2RF332	"Replacement of aortic valve using zooplastic tissue, rapid deployment technique, percutaneous approach, new technology group 2"	892	NO	1022	NO	1562	NO	N/A	NO	"3,476"
X2RF432	"Replacement of aortic valve using zooplastic tissue, rapid deployment technique, percutaneous endoscopic approach, new technology group 2"	2	NO	5	NO	10	NO	N/A	NO	17
XHRPXL2	"Replacement of skin using porcine liver derived skin substitute, external approach, new technology group 2"	158	NO	200	NO	201	NO	N/A	NO	559
XNS0032	"Reposition of lumbar vertebra using magnetically controlled growth rod(s), open approach, new technology group 2"	0	YES 	21	NO	31	NO	N/A	NO	52
XNS0332	"Reposition of lumbar vertebra using magnetically controlled growth rod(s), percutaneous approach, new technology group 2"	0	YES 	1	NO	0	NO	N/A	NO	1
XNS3032	"Reposition of cervical vertebra using magnetically controlled growth rod(s), open approach, new technology group 2"	0	YES 	12	NO	16	NO	N/A	NO	28
XNS3332	"Reposition of cervical vertebra using magnetically controlled growth rod(s), percutaneous approach, new technology group 2"	0	YES 	0	NO	0	NO	N/A	NO	0
XNS4032	"Reposition of thoracic vertebra using magnetically controlled growth rod(s), open approach, new technology group 2"	0	YES 	11	NO	23	NO	N/A	NO	34
XNS4332	"Reposition of thoracic vertebra using magnetically controlled growth rod(s), percutaneous approach, new technology group 2"	0	YES 	0	NO	0	NO	N/A	NO	0
XRG0092	"Fusion of occipital-cervical joint using nanotextured surface interbody fusion device, open approach, new technology group 2"	1	NO	1	NO	0	NO	N/A	NO	2
XRG1092	"Fusion of cervical vertebral joint using nanotextured surface interbody fusion device, open approach, new technology group 2"	43	NO	34	NO	21	NO	N/A	NO	98
XRG2092	"Fusion of 2 or more cervical vertebral joints using nanotextured surface interbody fusion device, open approach, new technology group 2"	137	NO	77	NO	61	NO	N/A	NO	275
XRG4092	"Fusion of cervicothoracic vertebral joint using nanotextured surface interbody fusion device, open approach, new technology group 2"	6	NO	3	NO	3	NO	N/A	NO	12
XRG6092	"Fusion of thoracic vertebral joint using nanotextured surface interbody fusion device, open approach, new technology group 2"	2	NO	3	NO	2	NO	N/A	NO	7
XRG7092	"Fusion of 2 to 7 thoracic vertebral joints using nanotextured surface interbody fusion device, open approach, new technology group 2"	3	NO	4	NO	1	NO	N/A	NO	8
XRG8092	"Fusion of 8 or more thoracic vertebral joints using nanotextured surface interbody fusion device, open approach, new technology group 2"	0	NO	0	NO	0	NO	N/A	NO	0
XRGA092	"Fusion of thoracolumbar vertebral joint using nanotextured surface interbody fusion device, open approach, new technology group 2"	6	NO	4	NO	2	NO	N/A	NO	12
XRGB092	"Fusion of lumbar vertebral joint using nanotextured surface interbody fusion device, open approach, new technology group 2"	75	NO	127	NO	146	NO	N/A	NO	348
XRGC092	"Fusion of 2 or more lumbar vertebral joints using nanotextured surface interbody fusion device, open approach, new technology group 2"	52	NO	68	NO	59	NO	N/A	NO	179
XRGD092	"Fusion of lumbosacral joint using nanotextured surface interbody fusion device, open approach, new technology group 2"	55	NO	70	NO	104	NO	N/A	NO	229
XW03372	"Introduction of inactivated coagulation factor xa into peripheral vein, percutaneous approach, new technology group 2"	8	NO	4	NO	337	YES	N/A	YES	349
XW03392	"Introduction of defibrotide sodium anticoagulant into peripheral vein, percutaneous approach, new technology group 2"	8	YES	3	YES	6	YES	N/A	NO	17
XW04372	"Introduction of inactivated coagulation factor xa into central vein, percutaneous approach, new technology group 2"	2	NO	0	NO	35	YES	N/A	YES	37
XW04392	"Introduction of defibrotide sodium anticoagulant into central vein, percutaneous approach, new technology group 2"	1	YES	1	YES	6	YES	N/A	NO	8
XW0DX82	"Introduction of uridine triacetate into mouth and pharynx, external approach, new technology group 2"	5	YES	4	YES	1	NO	N/A	NO	10
